Altimmune Inc
NASDAQ:ALT
| Market Cap (Intraday) | 563.51M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $13.77 |
| 50-Day MA | $13.26 |
| 200-Day MA | $13.75 |
Altimmune Inc Stock, NASDAQ:ALT
910 Clopper Road, Suite 201S, Gaithersburg, Maryland 20878
United States of America
Phone: +1.240.654.1450
Number of Employees: 43
Description
Altimmune, Inc. is a clinical stage immunotherapeutic biotechnology company. It focuses on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. The company's portfolio includes RespirVec and Densigen that targets to stimulate the elements of the human immune system to treat respiratory diseases, chronic infections, and cancer. Altimmune was founded in 1997 and is headquartered in Gaithersburg, MD.